干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 394543|回复: 255
go

Iron, lipocalin, and kidney epithelia

Rank: 1

积分
威望
0  
包包
0  
发表于 2009-4-21 13:39 |显示全部帖子
作者:Jun Yang, Kiyoshi Mori, Jau Yi Li, and Jonathan Barasch作者单位:Department of Medicine and Anatomy and Cell Biology, College of Physicians and Surgeons of Columbia University, New York, New York 10032 , x0 d& F+ Z; k# U% P7 ^9 Y
                  0 L. B4 S$ ~5 _. T
                  
' h3 ^3 C& k8 I- I% p( {0 A/ ?          ; p5 T4 ^1 |* ^% w/ u5 o+ o7 O
                        
' {/ a* t( w3 |& Z' A, q6 n            
/ _5 D5 Z6 N- M" b, N, i. u            
3 q) d- t" g/ \' W: |+ [            
) v2 U5 l4 {! R! C  Z) k            
- }. g( Y- _. ~: F" P7 {$ Q9 j                     
3 F6 |; E% n4 L" N* _( p        # H& k: Z8 R  t7 S/ V# w6 Y
        * r6 e( @; v8 F, l. t
        ; ^, _- s$ r; w3 ?
          【摘要】. F2 {: \1 R' }" f3 g: |9 f5 ?
      Brilliant new discoveries in the field of iron metabolism have revealed novel transmembrane iron transporters, novel hormones that regulate iron traffic, and iron's control of gene expression. An important role for iron in the embryonic kidney was first identified by Ekblom, who studied transferrin (Landschulz W and Ekblom P. J Biol Chem 260: 15580-15584, 1985; Landschulz W, Thesleff I, and Ekblom P. J Cell Biol 98: 596-601, 1984; Thesleff I, Partanen AM, Landschulz W, Trowbridge IS, and Ekblom P. Differentiation 30: 152- 158, 1985). Nevertheless, how iron traffics to developing organs remains obscure. This review discusses a member of the lipocalin superfamily, 24p3 or neutrophil gelatinase-associated lipocalcin (NGAL), which induces the formation of kidney epithelia. We review the data showing that lipocalins transport low-molecular-weight chemical signals and data indicating that 24p3/NGAL transports iron. We compare 24p3/NGAL to transferrin and a variety of other iron trafficking pathways and suggest specific roles for each in iron transport.
' l1 @+ P) o& X& q# F1 n- M! `          【关键词】 metanephric mesenchyme induction neutrophil gelatinaseassociated lipocalin NGAL p transferrin embryo
: d& O# q$ M8 K: F/ F# L1 g                  ----------
+ m6 U$ M4 u; |2 t' I1 z! @
& P5 |8 L4 }! H& C8 q, MTHE KIDNEY FORMS FROM THE interaction of an epithelial tubule called the ureteric bud and metanephric mesenchymal cells ( 103 ). The ureteric bud produces the collecting ducts, whereas the mesenchymal cells produce the glomeruli and tubules of the nephron. Mesenchymal cells convert into epithelia and form nephrons after receiving signals from the ureteric bud ( 15, 29, 42, 44, 61, 71, 103, 106, 115, 116, 119 ). The ureteric bud has been shown to control the growth of the mesenchyme (for example, by FGFs) ( 4, 92 ), the expression of the essential Wnt-4 gene (for example, by Wnt-6) ( 60 ), and the expression of cohorts of epithelial proteins [for example, by leukemia inhibitory factor (LIF)] ( 6, 95 ).
8 p  Y& `9 o8 a! [9 X3 C
& p! R" ^' [1 p$ CIn this review, we describe a new ureteric bud protein called 24p3 (mouse) or neutrophil gelatinase-associated lipocalcin (NGAL; human) and review its relatives in the lipocalin superfamily. 24p3/NGAL induces epithelial development, but it neither targets the same mesenchymal cells as Wnt-6/Wnt-4 or LIF, nor does it activate the same type of signaling mechanism. We hypothesize that 24p3/NGAL is a novel signaling molecule and iron transporter, and we speculate that it is a new member of the non-transferrin-bound iron pool (NTBI). We describe general mechanisms of iron transport and the settings in which 24p3/NGAL and the NTBI pool are active. Last, we compare iron transport in the developing and adult kidney. Iron metabolism in fetal development is topical: 18% of human pregnancies in the industrialized countries are iron deficient, as are 38-55% of pregnancies in Africa and 62-88% in India, and worldwide the total affected births may near one billion ( 14 ). However, because little is known about embryonic mechanisms of iron handling, we have included a number of hypotheses and suggested experiments.7 r# F$ [0 t* w: H- V; X. z$ v
- w# u% t: l* ~
24p3/NGAL INDUCES EPITHELIA2 `+ x- w! l+ x

- I" \. Z' i! T. hTo identify novel ureteric bud factors that activate the mesenchyme, we separated rat metanephric mesenchyme (for the mouse, see Refs. 6 and 60; other species, such as humans, have not been tested) from its ureteric bud ( E12-E14 ) and treated the mesenchyme with soluble ureteric bud proteins. The ureteric bud proteins were obtained from ureteric bud cell lines ( 3 ), and active proteins were purified to homogeneity by chromatography.
: C5 r8 g1 a2 C+ B. ]2 n1 h" F
0 X8 K. _$ z' e( _4 _; M. JWhen metanephric mesenchyme is treated with ureteric bud proteins, the cells undergo three to five cycles of proliferation ( 133 ) and rapidly express epithelial E-cadherin, zonula occludens-1, and laminin- 5 (by 48 h of the addition of ureteric bud proteins). By 2-4 days of treatment, morphological epithelia appear, and by 7-9 days tubules and finally segmented nephrons have formed. This response was due to two sets of ureteric bud proteins. The first set maintained competent epithelial progenitors for days-week in culture (e.g., "mesenchymal growth TGF- tissue inhibitor of metalloproteinases-2) ( 4, 5, 67, 92 ) but did not cause extensive growth or any evidence of epithelial conversion. The second set of molecules had no survival activity but, when combined with one of the growth factors, induced proliferation followed by tubulogenesis (e.g., LIF, TGF- ) ( 95, 132, 133 ).
! K/ l4 g' L& p1 z+ h, y- i( H0 _7 ?% m
One ureteric bud protein induced mesenchymal growth and tubulogenesis with an unusual delay, suggesting the selection of an undocumented subset of mesenchymal cells. We purified this activity and identified a member of the lipocalin family, called 24p3 [homologue of human neutrophil gelatinase-associated lipocalcin (NGAL)]. Cloned versions of 24p3 and NGAL confirmed the inductive activity, and a variety of techniques showed that 24p3/NGAL was expressed by the ureteric bud and not by metanephric mesenchyme in vivo ( 133 ). This identification was notable because there have been very few functional data for lipocalin-type proteins. In addition, 24p3/NGAL did not acutely stimulate signal transducers and activators of transcription factors (STATs) or -catenin activity (Barasch J, unpublished observations), typical of other kidney inducers, such as LIF and the Wnts ( 95 ), indicating that it activates other types of signaling pathways.
4 a4 N: R* s* H4 j0 ?: K
( O+ a7 I6 w5 ^& Y! V0 kEXPRESSION OF 24p3/NGAL BY ADULT EPITHELIA1 M# l2 ^8 _1 z6 c) U5 g- D6 o# u
4 v. }  q: k- j0 X; {* Q
24p3 Was first identified in mouse kidney cells transfected with SV40 T antigen ( 56 ), and NGAL was detected as a protease resistant monomer, homodimer, and metalloproteinase-9-linked heterodimer ( 68, 131 ) from neutrophils. These proteins are very highly expressed by adenocarcinoma of bowel and breast ( 87, 111 ) and by epithelia of diverticulitis, ulcerative colitis, and Crohn's disease. The expression of 24p3/NGAL was related to inflammation, because epithelia lying outside of the inflammatory zone did not express this protein. Additional correlations between 24p3/NGAL and inflammation have been reviewed ( 10, 128, 129 ) and should be contrasted with the limited expression of these proteins in the normal adult and embryonic animal ( 24, 38, 39, 111, 135 ).- l% N# w6 y, [, J2 g
! |4 E: i1 x5 ^5 P- m. s8 J
An explanation for the overexpression of 24p3/NGAL as a result of inflammation or malignancy has been lacking. One additional experiment showed that lipocalins can "enhance" the phenotype of adult epithelia. Introduction of a lipocalin called glycodelin into human breast carcinoma MCF-7 cells resulted in the de novo expression of E-cadherin, -catenin, and cytokeratins 8 and 18 ( 64 ), suggesting that a variety of lipocalins might regulate critical epithelial proteins in an autocrine manner. Glycodelin is also expressed by a subset of epithelia (exocrine glands and placental endothelia) ( 108 ), suggesting that different lipocalins regulate different types of epithelia. These data support a role for 24p3/NGAL as a regulator of the epithelial phenotype in embryo and adult., k& M/ D/ u3 j% w/ v
5 \  F) ]) ~! W% E! O  T
However, the observation that 24p3/NGAL is highly expressed during the involution of the mammary gland and the uterus ( 100 ) suggested the alternative hypothesis that 24p3/NGAL mediates apoptosis. Furthermore, the withdrawal of interleukins from pro-B cells ( 26 ) resulted in the marked expression of 24p3, as well as the onset of apoptosis. 24p3 Was proximate to cell death because purified NGAL produced the same response as the withdrawal of the interleukin, including changes in BAX phosphorylation and the repression of activating transcription factor (ATF)x (ATF-5) ( 93 ) by proteosome-dependent degradation. ATF-5 is activated during cell-cell signaling, and it regulates cAMP-responsive elements. These data suggest that epithelia express 24p3/NGAL to reduce the population of inflammatory cells or perhaps to regulate their own demise, rather than to induce or maintain epithelial polarity. Further analysis of these data requires the identification of the 24p3/NGAL receptor and its signaling mechanisms (see below) and an analysis of the ATF family in embryonic kidney. In addition, to determine whether 24p3/NGAL accelerates or inhibits any of these processes, inspection of a 24p3/NGAL-deleted animal might be useful.2 ?: y! n, p" _/ C& F) Q
. }1 K& m& N  Q" P/ o2 H
LIPOCALINS TRANSPORT SMALL-CHEMICAL SIGNALS
  o0 ]8 Q6 q! Y: ^, W3 I" E* a- ~  F3 d# w5 o( p
What is a lipocalin? A family of over 20 small, soluble proteins has been defined predominately on the basis of a highly conserved 3-dimensional folding pattern. The structure is a continuous eight-stranded, anti-parallel -sheet that forms a squat -barrel enclosing a cavity. In addition, outside of the -barrel there is a 3-10 helix at the NH 2 terminus and a -helix at the COOH terminus. Two or three short segments located in parts of the -barrel and helices are conserved throughout the family, whereas overall identity between these proteins is quite low ( 20%).3 N- b+ K, ]$ Z! N1 Q

0 o  P$ d; @4 ?8 d: K! v5 [The cavity within the -barrel is thought to bind and transport a variety of ligands ( 36 ). The best example of a carrier function comes from the study of purpurin ( 105 ) and the retinol binding protein (RBP) ( 84 ). These two lipocalins deliver retinol, the precursor of retinoic acid. Confirmation that RBP transports and delivers retinol comes from the deletion of RBP, which resulted in a deficiency of retinol in the eye ( 122 ). However, the receptor for RBP in the eye is not yet certain. In the proximal tubule of the kidney, megalin acts as an apical RBP receptor, capturing filtered RBP by endocytosis ( 22, 78, 109 ). The deletion of megalin resulted in the appearance of retinol-RBP and retinol-RBP-transthyretin in the urine and their depletion from the proximal tubule, verifying that RBP traffic in the kidney is regulated by megalin. These studies demonstrate that lipocalins are carriers of low-molecular-weight chemicals that in some cases are delivered to cells by receptor-mediated endocytosis.
1 i" b* @1 r5 o0 A4 E- i2 l9 X
, K, o8 N+ s* \. K' W, P5 MA second example of a carrier function for a lipocalin comes from the nitrophorins 1-4, which are produced in the salivary glands of Rhodnius prolixus, the vector of Chagas disease. These molecules sequester nitric oxide with a Fe 3  -heme prosthetic group and deliver nitric oxide to induce local vasodilation in the victim of a bite ( 81, 126 ). The Fe 3  -heme site also binds and sequesters histamine in exchange for nitric oxide, and this might limit the inflammatory reaction to these vector proteins. Nitrophorins are the first known nonglobin, heme-containing proteins, and like RBP, appear to play a role in local transfers of important low-molecular-weight chemicals.
9 _6 x$ e6 i/ r0 i% n3 ~0 ]# O+ h1 r  f/ K$ R. c# C, u9 g' ]
A more complex function is suggested for the major urinary proteins (MUPs) of mice. These proteins are thought to deliver volatile pheromones ( 13, 82 ). However, they may induce mating behavior by a second mechanism as well, because peptides from MUPs are active. This suggested that these lipocalins are bifunctional proteins ( 59 ). This type of analysis is not available for other members of the lipocalin family.( i$ C1 m% F, X$ e3 E

8 _8 \6 K  g6 V* ~7 nTaken together, these data show that the lipocalins function in intracellular chemical signaling, delivering low-molecular-weight cargo. However, the identification of ligands is still ongoing and is of great interest for 24p3/NGAL, grasshopper lazarillo ( 102 ), which is expressed by neuronal growth cones and tip cells of the Malphigian tubule, and for glycodelin, which is readily endocytosed by placental endothelia ( 136 ). Apo-lipocalins may also signal, but the data are presently limited to one experiment ( 59 ).
7 @% a0 x: C: }2 @9 G- j2 K3 Q" b" x5 `' ?2 ^+ ~
HYPOTHESIS: 24p3/NGAL LIPOCALINS TRAFFIC IRON
+ B  n6 n7 d8 Z" G; k
8 M6 N1 U) _; z; ^& FWe hypothesize that 24p3/NGAL transports iron. Transport of iron might require a cofactor, because bacterially cloned NGAL contains enterobactin, a small ringed structure that binds iron (siderophore) ( 83 ). These data were obtained by X-ray crystallography and molecular modeling ( 41 ). In fact, expression of the protein in bacteria inhibited their growth until additional iron was added to the cultures, suggesting that the cloned 24p3/NGAL bound siderophore-iron in situ ( 41 ).
- B6 f  \& F6 X$ m3 c
0 T% E8 t& _( d3 M7 N& u3 I( rMammalian-expressed 24p3/NGAL also captures iron. The data ( 133 ) include 1 ) the copurification of iron and ureteric bud 24p3 in immunoprecipitations and column chromatography; 2 ) the time- and temperature-dependent, saturable accumulation of iron in many cell lines incubated with 24p3; 3 ) the upregulation of ferritin protein and the downregulation of transferrin receptor-1 protein in cells incubated with 24p3/NGAL, indicating the delivery of sufficient quantities of iron to regulate iron-dependent genes; 4 ) the delivery of 24p3 iron by endocytosis into compartments containing the divalent metal transporter; and, last, 5 ) the induction of the metanephric mesenchyme by iron-24p3/NGAL but not by gallium-24p3/NGAL ( 133 ). It is also notable that another lipocalin, the tear lipocalin (LCN-1), is inducible by iron ( 75 ), and many of these findings are also typical of transferrin ( 28, 120, 130 ) and perhaps lactoferrin ( 11, 12 ) but distinguish these proteins from the melanotransferrin pathway ( 37 ). The missing data from this list are an identification of a mammalian homologue of the bacterial siderophore. However, there was a reddish low-molecular-weight substance in the initial steps of purification of 24p3/NGAL, and there are older reports of low-molecular-weight siderophores produced by mammalian cells ( 25, 34, 62 ).- E" Z+ p. V' G

" d1 B9 }9 [8 d: Q8 X8 H: P6 q, R) bThese data support the idea that 24p3/NGAL participate in iron transport and could explain various phenomena associated with this lipocalin. Iron trafficking is thought to be essential for epithelialization of the developing kidney ( 30, 73, 74 ), and lipocalin, produced in situ by the ureteric bud, might provide an alternate to the transferrin pathway. This idea would be most strongly validated by analysis of animals without the transferrin receptor. Second, 24p3/NGAL might be a member of the nontransferrin pool of iron carriers. In particular, 24p3/NGAL could redirect iron acquisition from bacteria to mammalian cells and traffic iron in states of iron overload. These speculations are not exclusive of other types of signaling by 24p3/NGAL, and we await identification of the 24p3/NGAL receptor to further test these possibilities.
/ Q" q) |3 \' S- Q3 K3 _1 e3 }9 @  |; _! B5 i5 j; _
MANY SOLUTIONS TO THE PROBLEM OF IRON TRANSPORT
. |1 `7 a- K( W& b
; a. h6 ^7 f7 R8 f  ]$ eIron must be bound to another molecule to be transported from one site to another. This is because in its common oxidized form (ferric or Fe 3  ), iron is entirely insoluble (Ksp 10 -17 M), whereas reduced iron (ferrous or Fe 2  ) is soluble (Ksp 10 -1 M) ( 69 ) but reactive (Fenton reaction) ( 49 ). Hence, iron traffic must start with the oxidation of Fe 2  to Fe 3  by ceruloplasmin or hephaestin (a duodenal homologue of ceruloplasmin) ( 123 ), or else iron overload in basal ganglia and liver (Wilson disease) ( 88 ) results from defective mobilization.
5 _4 _+ f. |; L8 K7 C7 s" E4 Y7 L& y
After iron is oxidized, it is sequestered by transferrin ( 51 ). In fact, essentially all circulating iron in the adult is associated with transferrin, because of a very high affinity for iron at neutral pH (10 -20 M), and transferrin is usually only partially saturated ( 96 ). Transferrin-Fe 3  is imported by nearly all cells after binding transferrin receptors 1 (ubiquitous) and 2 (in hepatocytes), which then carry transferrin into endosomes ( 97 ). Transferrin has a unique pH sensitivity for Fe 3 , and this allows the release of iron but the recycling of apo-transferrin from specialized endosomes ( 28, 120, 130 ). As a result, transferrin efficiently transports the majority of iron in the adult ( 77 ).
6 A) ?* n* D) `+ O" }! R: C
2 _  g4 v* ]3 J7 }% g3 R- K7 NHowever, startling new data show that transferrin is not the only molecule that can traffic iron. hpx/hpx Mice essentially lack transferrin ( 25, 58, 117 ) and as a result are severely anemic, but their Kupffer cells contain 10 times more iron than those of their littermates ( 80 ). This observation suggests that iron exit may require transferrin (or another desaturated acceptor protein) but that iron delivery does not. Atransferrinemic and hypotransferrinemic humans also exist ( 52, 53 ). They too have severe defects in hematopoesis, but most epithelial organs are said to be "normal," including gross kidney functions (personal communication, Dr. Y. Wada, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan; 53). In fact, mice lacking TRR1, the major transferrin receptor, can at least initiate epithelial organogenesis before succumbing to the effects of anemia, further suggesting that nontransferrin iron carriers are sufficient for nonhematopoetic tissues ( 76 ). These data graphically demonstrate the multiplicity of iron transport mechanisms.# S4 E. P0 O9 S* \& k3 |5 ~5 l

: E% s% D; R8 s. o& HThe alternative to transferrin-iron is called NTBI. The pool has been documented in a variety of iron overload syndromes when transferrin is saturated ( 101 ), including hemochromatosis (69% of patients) and end-stage renal disease (22% of patients) ( 16, 17, 50 ). Most interestingly, 18% of umbilical cord blood samples contained NTBI ( 31, 50 ), probably because transferrin is less abundant in the human fetus than in the mother (see below) and as a result of incomplete interchange of these pools. Hence, NTBI is known to mediate some component of iron delivery, particularly in iron overload, possibly in gestation, and, we speculate, also in deletions of the transferrin pathway., q% W% ?; e% ~7 b( |  ~2 U/ r

. G+ W3 @/ Y4 d' l3 gThe largest gap in these data is the identification of the components of NTBI. Low-molecular-weight non-transferrin iron carriers have been partially purified but never clearly identified ( 25, 34, 62 ). Candidates include iron salts, such as iron ascorbate, citrate, or nitrilotriacetate, which display saturable uptake in cell lines ( 46, 63, 66, 112 ). Other candidates have been defined by an affinity for iron that is relatively less than transferrin ( 16, 17, 50 ). Typically, low-affinity binding is measured by iron absorption on ion-exchange beads ( 55 ) or chelators such as oxalate or EDTA, followed by transfer to a fluorescent or DNA binding molecule, or transfer through an ultrafiltration membrane. These chelators distinguish the NTBI pool because they do not remove iron from transferrin. This definition is inclusive of abundant serum molecules like albumen, but whether it also includes 24p3/NGAL is not yet clear.  @5 ?* R  e; w, B) x
  T3 q% }4 n6 z: E
How does iron enter the cell cytoplasm? Divalent metal transporter (DMT)-1, 3 -integrin, and stimulator of iron transport (SFT) can transport iron from transferrin and from NTBI. DMT-1 is a divalent metal transporter that is located on the apical membrane of the duodenal enterocyte and in endosomes of most cells. It captures Fe 2  that has been reduced from dietary Fe 3  in the duodenum ( 19, 45, 80 ) and from Fe 3  -transferrin and apparently from Fe 3  -NTBI in endosomes ( 35, 43, 104, 113 ). Because DMT1 is an Fe 2  -H   symporter, the recovery of iron by DMT1 is stimulated by the acidity of the duodenal contents and by the activity of vacuolar H   -ATPase ( 45 ). Conversely, the capture of iron is blocked by the alkalinization of endosomes ( 40 ). These findings stress the complexity of iron capture, because intracellular DMT1 must colocalize with a ferrireductase, the vacuolar H   -ATPase, and soluble carriers of iron. Precise localization of these components in different organs is a central aim of research in iron metabolism ( 113 ). In fact, the intracellular itinerary of DMT1 is not fully established, including whether it traffics to the cell surface of nonenterocytes or whether it is present in more than one population of vesicles. The importance of the DMT1 pathway is established by two naturally occurring mutations, the mk mouse and the Belgrade rat ( 19, 35, 45 ), that feature severe anemia.9 _! i. w7 O8 _+ K! x% b

1 l# f# \  ?0 X: k+ N1 x) C4 O4 k& HFerric iron can also be transferred to the cytoplasm by binding a complex composed of 3 -integrin, mobilferrin, and a flavin monooxygenase. Evidence for this complex includes (see also Ref. 7 ) the specific blockade of ferric iron transport by antibodies to 3 -integrin and the unique specificity for Fe 3 , rather than Fe 2  or other divalent metals that characterize DMT1 ( 23 ). However, DMT1 might be part of the integrin- 3 -mobilferrin pathway ( 118 ), suggesting that it may modify DMT1 specificity. Whether these components transport iron from the cell surface or from endosomes is presently not clear, because most of these proteins are intracellular ( 107 ).
0 M2 `7 n; Q6 b$ j! a1 E8 y* ]. q9 w
" [" F+ i0 l- j3 IA third pathway for iron transfer is SFT protein ( 47 ). SFT is highly expressed in apical plasma membranes of the intestine, lung, and kidney, as well as the brain ( 70 ) and in transferrin-recycling endosomes. SFT has six membrane-spanning domains and a cytoplasmic iron-binding motif (REXXE), which is necessary for iron transport ( 134 ). In addition, iron transport requires binding and hydrolysis of ATP, despite the absence of a Walker motif or any requirement for a transmembrane gradient pH or potential ( 48 ). Transfection of SFT cDNA enhances both transferrin and NTBI transport but not the transport of other divalent metals. All of these characteristics demonstrate that SFT is distinct from DMT1, and hence it is plausible that SFT provides an alternative route for iron transport that mitigates the lethality of defects in DMT1. In fact, SFT can dimerize and mimic the 12 membrane-spanning structure of DMT1. The importance of SFT is also suggested by its upregulation in the setting of iron depletion ( 8 ). However, there is more to learn about this iron transport pathway because some data show that ferrous and not ferric iron is the transported species ( 134 ), perhaps indicating some shared mechanisms with DMT1.
9 J' x2 [6 q8 I8 F+ b
$ t$ u; k: A1 _& `3 [In conclusion, while the transferrin pathway has physiological predominance in wild-type and DMT1 is the critical transmembrane transporter, there are many other routes for iron transfer that may dominate different settings and with different effects.
0 d" I( v+ D* X% G  H8 M
& Y4 a3 i* d  R5 f% {8 ]24p3/NGAL VS. TRANSFERRIN IN THE DEVELOPING KIDNEY: NOT THE SAME5 F0 Y/ p) N: j: V

3 t/ w5 ^' ^0 G& G+ Q1 g3 M: S- F+ YIf NTBI can substitute for transferrin in some developing organs, the important question is whether 24p3/NGAL is one of these substitutes. First, it would be valuable to know where 24p3/NGAL and its putative receptor are expressed in normal gestation and whether they are overexpressed in mice and humans with deletions of the transferrin pathway.
/ h7 s- z& v+ W/ k1 b* d2 }0 x1 T( P# h. x
Second, it would be valuable to test different iron carriers in explanted embryonic organs to see whether they can replace transferrin or whether they have distinct functions. For example, Fe 3  -transferrin must be added to minimal essential media to permit robust branching of the ureteric bud, conversion of mesenchyme, and growth of nephrons ( Fig. 1 ) ( 30, 73, 74 ). 24p3/NGAL can also rescue cultures that are iron poor, but not to the same extent as transferrin ( Fig. 1 ). In fact, in isolated metanephric mesenchyme these molecules are complementary rather than redundant. Both 24p3/NGAL and transferrin must be added to the explant to generate nephrons: tubulogenesis was possible when 24p3/NGAL was added before transferrin (by 24-48 h) but not after. This suggested that 24p3/NGAL rescued epithelial progenitors from apoptosis, whereas transferrin does not have this activity ( 132 ).) v  e0 r- }5 ?  g9 D& E

. x7 H1 E6 C  t- c, T$ SFig. 1. Partial rescue of transferrin by 24p3/neutrophil gelatinase-associated lipocalcin (NGAL). Mouse kidneys were harvested at embryonic day 11.5 ( E11.5; ureteric bud was T-shaped) from animals expressing -galactosidase in the BF-2/Foxd1 locus (marking stromal cells) and were cultured in a low-iron media (DMEM) for 6 days. The media was supplemented ( 67 ) but without transferrin. A : while the stroma remained viable (blue; nuclear staining), there was limited branching of the ureteric bud and very limited expansion or development of the mesenchyme. B and C : when either iron-loaded 24p3/NGAL (doubly purified recombinant protein; 50 µg/ml) or holo-transferrin (50 µg/ml) was added to the media, the ureteric bud underwent branching morphogenesis and the metanephric mesenchyme expanded, resulting in the centrifugal displacement of stromal cells. However, the effect was more dramatic with transferrin than with 24p3/NGAL. The data suggest that both molecules deliver iron to the mesenchyme by no redundant pathways.4 h: ^3 P4 ]( W( M9 j

' ?. Z+ m5 ~" R9 ]* }* h( WFunctional dissimilarity between 24p3/NGAL and transferrin could result from activities other than iron delivery, which we have not ruled out. On the other hand, we found that the two proteins targeted different mesenchymal cells ( Fig. 2 ). 24p3/NGAL was taken up throughout the kidney, but most prominently at the cortical margin, which is composed of mesenchymal (early epithelial progenitors?) and stromal progenitors. In contrast, the transferrin domain was restricted to Pax-2  , WT1  , Wnt-4   mesenchymal cells and their progeny that surround the ureteric bud (late epithelial progenitors and nascent epithelia, respectively). These data suggest that 24p3/NGAL and transferrin act sequentially in lineally related cells.
, a, a3 k  g8 d" ~! o; F; y  p) l: |& s+ J2 ^$ n3 F' v
Fig. 2. Distinct targeting of embryonic mesenchyme by 24p3/NGAL and transferrin. Rat kidneys [ E13.5 ( A ) and E15 ( B )] were incubated with fluorescein-transferrin (green) and Alexa 568- 24p3/NGAL (red) for 3 h. A unique distribution of the 2 molecules is found. 24p3/NGAL is incorporated throughout the kidney, but especially at the cortical margin (contains stromal cells and early epithelial progenitors), whereas transferrin is incorporated only by late epithelial progenitors and their progeny that surround the ureteric bud.; z/ _8 F1 |6 _( @
. f; O2 p1 q0 y% r9 T
From these data we speculate that transferrin-iron and non-transferrin-iron delivery may overlap but are not fully redundant. For example, transferrin receptor 1 is generally induced at the commencement of cell proliferation (by stem cell factor through the c-MYC pathway in hematopoeitic cells) ( 65, 110 ), but is not expressed during the initial part of the lineage. In the kidney, proliferation and conversion of late-stage epithelial progenitors in vitro were supported by transferrin, whereas the initial part of the lineage did not require this protein ( 30, 73, 74, 114 ). Similarly, lactoferrin is transiently expressed by the nasopharynx, proximal gut, and airway ( 124 ), and uteroferrin by the uterus ( 32 ). These data confirm the idea that the delivery of iron is specialized to specific stages of development and suggest that heterogeneity of iron delivery is a general principal in organ development.
; N7 I- v, e9 p4 B2 c$ ?  f: X% l7 w7 p2 e+ u, c+ K
HETEROGENEITY OF IRON TRANSPORT = VARIATION IN CYTOPLASMIC IRON?4 p! E8 [  e( g1 T! R. P7 }; |/ V

' ^* ]4 U& m$ e/ r" W' e6 ANot only might different carriers direct iron to different cells, but they also might deliver iron to different intracellular compartments ( 40 ). For example, incubation of erythroid cells with transferrin-Fe 3  resulted in the production of heme-Fe 3 , but incubation with non-transferrin-Fe 3  resulted in deposition of iron in a separate compartment (see Fig. 3 ). Perhaps, then, different iron transport systems produce different levels of cytoplasmic iron in lineally related cells. This quantity is important because it regulates transcription of many genes and the translation of others ( 69 ). In fact, ferritin ( Fig. 4 ), which is regulated by cytoplasmic iron, is most highly expressed in late epithelial progenitors adjacent to the ureteric bud, whereas peripheral cells had less expression. Eya, which is necessary for renal development ( 133 ), may also be regulated by iron and has a similar localization. The expression of different iron-dependent genes implies that late progenitors have a higher level of cytoplasmic iron than earlier cells, but measurement of this iron gradient awaits invention of a new type of probe ( 2 ).  [  A7 h  V7 L: A

# u& G3 B; F) _2 U  t) ^0 o' u! ?Fig. 3. Distinct subcellular trafficking of NGAL (red) and transferrin (green) in kidney cells. Species-matched ligands and cells were used. Steady-state labeling shows that the 2 proteins occupy different organelles, with limited overlap (yellow arrows).) o! F: [3 t/ r1 v& O" |8 K$ O
. N$ ]7 u" e: o! X4 h5 d) T
Fig. 4. Ferritin expression detected by immunocytochemistry in rat kidney ( E13.5 ). Late epithelial progenitors surrounding the ureteric bud (UB) express higher levels of ferritin than peripheral progenitors or stromal cells. A gradient of ferritin should (theoretically) reflect increasing levels of cytoplasmic iron ( 69 ).) f! v6 g. O" \! _8 ~, ^
' `, O( L2 f0 |$ V+ s8 X
THE ADULT KIDNEY IS A PRINCIPAL ORGAN OF IRON TRANSPORT7 C5 M- i) v0 ]! _
  f7 Z2 b  N. T" q" u
In rats, 0.5 mg/day of iron is filtered, but only 5 µg/day are excreted ( 125 ). In humans, urinary iron is not detectable ( 18 ). Iron reabsorption occurs in the thick ascending loop of Henle (TALH) and cortical collecting ducts ( 125 ). Indeed, adult rats express DMT1 on the apical cell surface of the TALH, distal convoluted tubule ( 33 ) intercalated cells of the cortical collecting ducts, and perhaps brush borders of the proximal tubule ( 20 ), whereas in other segments DMT1 is present only in endosomes.
7 f. |9 B8 M$ _/ h% h. D* M0 j: X
' ~8 {) n5 ]$ y+ Z8 L! E$ q6 CThere are complex kidney-specific mechanisms that regulate DMT1 expression and trafficking. Four forms of DMT1 are distinguished by two types of exon-1 and the presence or absence of an iron-responsive element (IRE) in the 3'-untranslated region that confers iron dependence on the half-life of mRNA. The duodenum mostly regulates the 1A  IRE transcript, whereas the kidney most highly expresses the 1B -IRE version ( 57 ), indicating much less flexibility in variation with iron load ( 57 ). Nonetheless, it would be interesting to measure urinary iron and DMT1 expression after changes in dietary iron ( 20 ). In addition, the DMT1-defective mouse (mk/mk) and rat (Belgrade) should also be examined to determine whether DMT1 is essential for iron recovery.( n8 d  M# F0 r$ A# i: O( P  e0 T0 z) L

& b6 n6 ?; O1 ]+ q7 D, RHowever, the kidney has other mechanisms to recapture iron, in addition to DMT1. Cubilin and megalin are present on the apical membrane of the proximal tubule and recover filtered transferrin, routing it to lysosomes, where it is degraded ( 72, 89 ). This pathway is quite unusual in that transferrin is usually recycled from the basolateral domain. However, the apical pathway is important because deletion of cubulin or megalin leads to urinary loss of transferrin. In addition, a number of disease-inducing permeability defects in the glomerulus cause urinary loss of transferrin ( 98, 121 ).
: m% s1 i% ?/ [+ b. [
3 B2 m% w+ p5 c* A/ M3 F! v9 LIt is also likely that 24p3/NGAL is filtered by the glomerulus and reabsorbed by the proximal tubule. 24p3/NGAL is present in the urine of normal animals and humans, but at low levels. In the setting of malignancy, the level of urinary lipocalin is increased, appearing as a 25- or 35-kDa monomer and a 50-kDa dimer, as well as higher molecular weight species cross-linked to matrix metalloproteinase-9 ( 131 ). One study using pathological specimens showed that NGAL is present in the proximal tubule in a patchy distribution, suggesting that the complex could be cleared (or synthesized) at this site ( 38 ). These studies introduce a second mechanism by which the kidney participates in the regulation of iron metabolism, the catabolism of iron-proteins.9 V+ S$ x* \* e6 G8 r- ^. v+ u
5 i' W# [7 I$ L
There are likely to be other mechanisms of iron recovery in the kidney that have not been explored. SFT ( 70 ), basolateral iron transporter ferroportin ( 27, 80 ), and hephaestin (or ceruloplasmin) ( 123 ) are expressed, but localization in the kidney needs to be determined to indicate whether these proteins recover iron from the filtrate. Furthermore, it will be necessary to determine whether these molecules are regulated by hepcidin ( 85, 86, 94 ), a circulating hormone that negatively regulates iron absorption in the gut. Perhaps this hormone increases iron loss in the urine, an effect that would be reminiscent of the regulation of phosphate by parathyroid hormone, but this is entirely speculative. Last, it would be important to determine whether pharmacological therapy enhances iron loss. One idea is to measure urinary iron after diuretic therapy, when the tubular flow rate is increased and other cations, such as K  , are lost. In addition, changes in the transapical membrane potential should affect iron reclamation, given that transport of iron by DMT1 is electrogenic (e.g., Bartter's syndrome) ( 54 ).
6 B5 I) r0 L: {8 ?+ p  B
8 I. k6 @) p! aIn sum, given the glomerular filtration of iron and a variety of recovery mechanisms throughout the nephron, these data show that the adult kidney is a principal organ of iron traffic.
$ e( H7 k: Q3 f) a
2 [! }# f) i3 l9 LDIFFERENT IRON TRANSPORT IN ADULT AND EMBRYO?. @' ]8 B$ ?" R0 Q5 G  E' O
! t8 }3 x- v+ b' p
The adult kidney provides a guide to the type of carriers and transporters that must be expressed by the time of birth. However, iron trafficking in the adult and embryonic kidneys must be quite different. First, the rodent mesenchyme expands from 10 4 cells to 10 5 nephrons in a 2-wk period, meaning that there is a dramatic requirement for iron absorption to support proliferation. Hence, the 1A  IRE DMT1 isoform may be expressed in embryo, rather than the non-IRE 1B form of the adult. Conversely, iron absorption by the developing nephron may be less stringent than in the adult because fetal urine is recycled through the amnion and the gastrointestinal tract ( 90, 91, 99 ). Third, neonatal blood contains NTBI ( 9, 31, 50 ), which is likely to traffic by pathways not found in the adult. In fact, because of low Po 2, high levels of ascorbate, and low levels of ceruloplasmin that have been found in the newborn, some of the circulating iron may be soluble Fe 2 .
! G2 h0 c: h+ l" K7 P0 @" K8 n
! ?- j* R% \  R- O- CThe presence of NTBI in the embryo, and the absence of a dramatic disturbance of organogenesis in animals lacking components of the transferrin pathway, may indicate that local, rather than long-range, transfers of iron are important in the embryo. For example, many metanephric mesenchymal cells become apoptotic, and it is not clear what happens to their iron. Perhaps ureteric bud 24p3/NGAL is present to scavenge this iron and return it to viable cells. While local transport mechanisms might play a role in iron trafficking in the embryo, this may not be important in the adult, except in the setting of inflammation and cell death, where we speculate that epithelia recapitulate a local mechanism of iron recovery by reexpressing 24p3/NGAL./ F5 U7 m6 u& G3 @/ V/ q) T

! d8 ?$ i9 M* h. Y2 q: ]3 UACKNOWLEDGMENTS4 X1 A# W8 h, x4 u
* R. a5 z; J6 o/ z1 ?% b6 q8 J$ J
J. Barasch is supported by Research Grant FY-00165 from the March of Dimes Birth Defects Foundation and by National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-55388 and DK-58872.
9 a; i! O+ ^; X4 A' u2 W* }& H. e# r1 E
Address for reprint requests and other correspondence: J. Barasch, Dept. of Medicine and Anatomy and Cell Biology, College of Physicians and Surgeons of Columbia Univ., 630 W 168th St., New York, NY 10032 (E-mail: jmb4{at}columbia.edu - g8 V# l* C$ I
          【参考文献】
* w0 ^6 w0 @+ O# d/ p2 a  Z Abboud S and Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275: 19906-19912, 2000.
5 O2 q5 S3 |  H  }
' k2 C7 m) O' g( R
) Y; I0 ~1 P# S2 z$ r, Y% @- i/ a
9 k3 Z* H( @5 _+ ~* }Barasch J and Li JY. Measurement of intracellular iron (Abstract). J Am Soc Nephrol 13: 504A, 2002.
! ]5 I; J% S" v: f: F4 W3 I5 Q* X: U: n+ g+ {! e

  [- D$ F+ i1 Z1 b; n6 h" m4 k5 U* k8 c1 [
Barasch J, Pressler L, Connor J, and Malik A. A ureteric bud cell line induces nephrogenesis in two steps by two distinct signals. Am J Physiol Renal Fluid Electrolyte Physiol 271: F50-F61, 1996.2 L# n' g* h% N' }* o: i+ |, p
) S8 Q" V2 t2 Z. z
6 k, G7 ~' R! s( _$ E0 D
+ r2 t! s) p. P
Barasch J, Qiao J, McWilliams G, Chen D, Oliver JA, and Herzlinger D. Ureteric bud cells secrete multiple factors, including bFGF, which rescue renal progenitors from apoptosis. Am J Physiol Renal Physiol 273: F757-F767, 1997., d& j' Q+ g$ C2 w

* f, R6 u- J6 \' j% Z
" `7 L: d* ~) Y* X9 r
" @% Q7 f1 u5 EBarasch J, Yang J, Qiao J, Tempst P, Erdjument-Bromage H, Leung W, and Oliver JA. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. J Clin Invest 103: 1299-1307, 1999.
- l! X  p0 L' \+ h7 q9 z1 ?4 v- y- v7 G

6 }# n" W# _/ }" |, r- m3 E
6 J% G+ Y) V3 qBarasch J, Yang J, Ware CB, Taga T, Yoshida K, Erdjument-Bromage H, Tempst P, Parravicini E, Malach S, Aranoff T, and Oliver J. Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell 99: 377-386, 1999.
  Y  R/ r6 z9 E, l1 P& G9 n! R' M
: z) q* G2 |* w; d+ \
, T2 |, F, @/ Y! C6 h) o% h& g8 G1 z: x# b
Barber M, Conrad ME, Umbreit JN, Barton JC, and Moore EG. Abnormalities of flavin monooxygenase as an etiology for sideroblastic anemia. Am J Hematol 65: 149-153, 2000.3 T6 H' j; V/ C1 B9 }2 w
1 F) ?' M8 ~/ E1 U% K) A6 g

: A9 z0 F# t9 F8 W$ @* D' ~. s- G$ B+ s7 m$ t; [1 B- h
Barisani D, Parafioriti A, Armiraglio E, Meneveri R, and Conte D. Duodenal expression of a putative stimulator of Fe transport and transferrin receptor in anemia and hemochromatosis. Gastroenterology 120: 1404-1411, 2001.% e, L/ X) m" P; N6 ~/ K! t* o: I
( E$ B% B/ `) f1 Q! {, ^

- Z( g! {1 u: z6 z( G/ O9 E/ T# `1 e2 f& x. m! _# w
Berger HM, Mumby S, and Gutteridge JM. Ferrous ions detected in iron-overloaded cord blood plasma from preterm and term babies: implications for oxidative stress. Free Radic Res 22: 555-559, 1995.3 I$ F  a& i/ ~% W" l) {; m, O) x

  W+ q: x2 I9 D6 @5 D& @7 K' U2 D2 f  _4 a* \5 i

/ }* ?) `0 ~* g& x8 ZBetsuyaku T, Nishimura M, Takeyabu M, Tanino M, Venge P, Xu S, and Kawakami Y. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with sub-clinical emphysema. Am J Respir Crit Care Med 159: 1985-1991, 1999.
8 `; J# o' l& S( h1 z" y2 g) b! C. }) I0 r9 S5 |
& L: Q8 h4 c: J9 T
# V) q8 P! @* R+ `) c2 J
Birgens H, Kristensen L, Borregaard N, Karle H, and Hansen N. Lactoferrin-mediated transfer of iron to intracellular ferritin in human monocytes. Eur J Haematol 41: 52-57, 1988.
; m1 t% |+ V+ b, \1 q. K) m
. h  j- v; Q- g, U- I2 H& m4 ~% f
6 z# n4 J( `& m9 k1 j
9 z9 F$ V/ }, C, Y. xBirgens HS. The monocytic receptor for lactoferrin and its involvement in lactoferrin-mediated iron transport. Adv Exp Med Biol 357: 99-109, 1994.
: v1 n+ B% Y- ^; m/ J( a8 D. r9 C; |& {1 ~5 w* X. M* m& o
7 d" q. O# ^  {; g, ?  p

$ Z. \; N# k' I0 I* DBishop JO, Clark AJ, Clissold PM, Hainey S, and Francke U. Two main groups of mouse major urinary protein genes, both largely located on chromosome 4. EMBO J 1: 615-620, 1982.
& x8 |9 z6 z" e) `3 C7 w6 J: p2 K% r
9 Z; m8 E/ F1 I# ?- c) I2 Q

/ w5 _2 {- Y- w" }: m" GBlot I, Diallo D, and Tchernia G. Iron deficiency in pregnancy: effects on the newborn. Curr Opin Hematol 6: 65-70, 1999.  }' S' g2 s: E; X
: X6 w9 M0 {% s/ y+ S/ Q

7 M' a; D  {- Z' f
2 {" b: q; o( P  b& jBoyden EA. Experimental obstruction of the mesonephric duct. Proc Soc Exp Biol Med 24: 572-576, 1927.; B3 B/ A% m8 o  t6 w3 E3 J

$ L4 v5 L9 g1 w3 g/ ?3 S& \" G2 i8 {  @$ A& f$ @( ^
5 ~3 g4 O- x, i9 `
Breuer W and Cabantchik ZI. A fluorescence-based one-step assay for serum non-transferrin-bound iron. Anal Biochem 299: 194-202, 2001.* k6 M5 ]3 X' c- i. d* U7 v  S

2 B6 ]5 n( V- X/ {9 u0 _, B
1 o! F1 V1 v) k0 W: I
* q5 Q0 L, s* A! I+ o. h2 OBreuer W, Ronson A, Slotki IN, Abramov A, Hershko C, and Cabantchik ZI. The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood 95: 2975-2982, 2000.4 O  l, w, B1 E0 Z

. g2 ?. ^% x% \7 C1 g& s2 L; K
( ^; N* a7 l' x* G# _  B1 ]7 U. O$ \: v: t8 m6 K7 ^  g
Buchman AL, Keen C, Commisso J, Killip D, Ou CN, Rognerud CL, Dennis K, and Dunn JK. The effect of a marathon run on plasma and urine mineral and metal concentrations. J Am Coll Nutr 17: 124-127, 1998.# B& Z5 @# [7 m0 D' ~# V
/ P, {; H3 r- F
0 M' n. k3 k1 p% w* F4 R
* S0 Q( M1 b7 W8 @) ^
Canonne-Hergaux F, Fleming MD, Levy JE, Gauthier S, Ralph T, Picard V, Andrews NC, and Gros P. The Nramp2/DMT1 iron transporter is induced in the duodenum of microcytic anemia mk mice but is not properly targeted to the intestinal brush border. Blood 96: 3964-3970, 2000.2 \, a/ N9 }8 V

4 I! K$ S  y1 ~5 D5 ]* o  m( h5 B8 H

. D- e- G" U, Q4 ^# l/ gCanonne-Hergaux F and Gros P. Expression of the iron transporter DMT1 in kidney from normal and anemic mk mice. Kidney Int 62: 147-156, 2002.
/ `* n& u2 q" r. A  A+ ]6 p3 t- o, u/ F7 }4 u8 ^. n

8 n3 z& X; B1 E
1 a$ @) H; R0 d# U& X; nCanonne-Hergaux F, Gruenheid S, Ponka P, and Gros P. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood 93: 4406-4417, 1999.
# w7 g4 i: S" i, G; A/ m
: e# g% F; m# o- W# Q$ \4 T2 \8 X9 ?( T4 n5 {3 V4 E; r

" C) s* K) Q/ V2 y! w& N; |8 G/ |Christensen EI, Moskaug JO, Vorum H, Jacobsen C, Gundersen TE, Nykjaer A, Blomhoff R, Willnow TE, and Moestrup SK. Evidence for an essential role of megalin in transepithelial transport of retinol. J Am Soc Nephrol 10: 685-695, 1999.& Z5 R- \; W$ L4 u

! e" u% K# x8 C% l  A. T% l" ^( e6 ~1 }. B* u$ |9 b
; w6 b6 b: V: W. [& r. ?* `- r8 ^
Conrad ME, Umbreit JN, Moore EG, Hainsworth LN, Porubcin M, Simovich MJ, Nakada MT, Dolan K, and Garrick MD. Separate pathways for cellular uptake of ferric and ferrous iron. Am J Physiol Gastrointest Liver Physiol 279: G767-G774, 2000.  a. K) U& M; z

- s% m. ~" {* P" m
9 L7 I1 w2 C3 f& a
' T, O, m7 T6 rCowland JB and Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45: 17-23, 1997.' h+ ?* C9 F9 i* @& Z' G( b

8 m, r- @/ ]* ^' p! u& J
; ~( \, V3 \# m7 L9 x, e7 @4 J7 Y4 N: C* r  ]2 D# P* F
Craven CM, Alexander J, Eldridge M, Kushner JP, Bernstein S, and Kaplan J. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc Natl Acad Sci USA 84: 3457-3461, 1987.
/ j/ l: Y7 q7 Y% i" E
* T4 q! @: H. {: M* c( i0 {+ Y/ M0 b2 `$ M! H* W$ Z. l
2 Z7 i1 v" O+ M$ e  ^: p/ n
Devireddy LR, Teodoro JG, Richard FA, and Green MR. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293: 829-834, 2001.
0 u9 B1 v7 V: y) Y" d; M* E& t; |& N% p$ e
; P0 X* Q3 M+ c6 k7 h2 q

& W2 N& x" M7 l* a. O1 z2 |Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, and Zon LI. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403: 776-781, 2000.% A# L0 k6 f; r! p8 j/ X+ P& q
. V9 k8 D, R3 G3 o6 S
5 b# C4 M0 H$ \- T' m$ m

- @% O& X; P( V% Y2 t) ]; wDunn KW, McGraw TE, and Maxfield FR. Iterative fractionation of recycling receptors from lysosomally destined ligands in an early sorting endosome. J Cell Biol 109: 3303-3314, 1989.
$ E/ B2 d# C* l. D& t; t4 z3 m2 J2 I, E7 W3 d, X' K

6 K, X9 ?! K) H% L) c& j4 J" k+ c4 Y7 Q
Ekblom P. Developmental regulated conversion of mesenchyme to epithelium. FASEB J 3: 2141-2150, 1989.
/ q5 \6 R4 v" h  P# X
9 {) P( ^0 g. X! v" ^5 _, W, f4 Q% u( J' Y
( l* o/ e1 g0 l. T, ]) t
Ekblom P, Thesleff I, Saxen L, Miettinen A, and Timpl R. Transferrin as a fetal growth factor: acquisition of responsiveness related to embryonic induction. Proc Natl Acad Sci USA 80: 2651-2655, 1983.
$ n: p( N) c" [/ F! N4 O+ |, H' G: R9 X6 ~, @2 Y+ C

/ m1 x6 U* A: ^# ^$ q3 V: }9 G! S
( y3 a1 J+ L% P( U) E1 S3 G5 Q4 HEvans PJ, Evans R, Kovar IZ, Holton AF, and Halliwell B. Bleomycin-detectable iron in the plasma of premature and full-term neonates. FEBS Lett 303: 210-212, 1992.+ Z1 z+ e" }" d) ^9 g  r8 B7 ^% n
2 O8 l6 {0 w1 H( h: p; z" q
* N4 |, |& @$ G7 |" d8 B2 ]# q
3 U* f' O5 a/ M0 a; p
Fazleabas AT, Bazer FW, Hansen PJ, Geisert RD, and Roberts RM. Differential patterns of secretory protein localization within the pig uterine endometrium. Endocrinology 116: 240-245, 1985.8 G/ Z- @8 Z" B' g/ \

3 V! ?( v+ b+ {1 ]9 I- m# W, {( V3 V# t3 |( ^

) i3 [5 B3 [2 }& pFerguson CJ, Wareing M, Ward DT, Green R, Smith CP, and Riccardi D. Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am J Physiol Renal Physiol 280: F803-F814, 2001.
1 n. ^- U+ }, y  {% z+ X+ h' x( b% u; Z1 s: ^
4 `* B) _) {1 C

& X% k! h& ?! I6 M) R; {9 @4 y0 |Fernandez-Pol JA. Isolation and characterization of a siderophore-like growth factor from mutants of SV40-transformed cells adapted to picolinic acid. Cell. 14: 489-499, 1978.6 ^# S5 c  \9 e: C

  j2 B' h, C7 v" j+ }- V8 o7 _+ Z
* l3 H' L4 f& h& o$ ?# l: d
* H, }6 f. N7 w% m1 |Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, and Andrews NC. Nramp2 is mutated in the anemic Belgrade ( b ) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 95: 1148-1153, 1998." r6 A  A# S0 R" r
. Y: P" Q, ~! {  w5 e+ f

2 T5 I/ `& F/ I! K: d1 ]: W7 I! h: I. v/ R4 C! R- o' f
Flower D, North A, and Sansom C. The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta 1482: 9-24, 2000.
7 k& `$ G- S) H' C, Z& [
, y* G# w; B7 @; n
6 b0 U" j/ J* e0 T) \8 M& h8 J
9 ^( e! r% g6 P. i" B5 u. q1 @Food MR, Sekyere EO, and Richardson DR. The soluble form of the membrane-bound transferrin homologue, melanotransferrin, inefficiently donates iron to cells via nonspecific internalization and degradation of the protein. Eur J Biochem 269: 4435-4445, 2002.
9 J8 t1 m/ R7 C4 O, f4 j
  }: d) M; ^% g  Y8 Z1 }. a$ R6 L! B  a% Z1 S" k5 G  ]- |& S

, f# k- g7 r& C2 P& ?+ L9 IFriedl A, Stoesz SP, Buckley P, and Gould MN. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J 31: 433-441, 1999.
! O% r( v' F" ?; [* x$ j+ ?) k8 }
+ A+ i+ S: t4 I: i- p+ M
+ s4 V1 G* L+ j) C
; R$ z# E7 }2 Q: S  nGaray-Rojas E, Harper M, Hraba-Renevey S, and Kress M. An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3. Gene 170: 173-180, 1996.
+ p4 ?6 I" \, l, ~& q$ E5 P" ~
5 [+ G5 D1 }; Z2 y3 `: F. c
) |7 Y3 P& G1 b+ V4 T; ?3 O& t# M, U3 G- O+ S3 ~% h) r0 l/ r6 D/ n
Garrick LM, Dolan KG, Romano MA, and Garrick MD. Non-transferrin-bound iron uptake in Belgrade and normal rat erythroid cells. J Cell Physiol 178: 349-358, 1999.
& q0 r& [$ H& [! e7 z) u3 t9 b2 I0 d  V1 I9 B
8 N) u# u9 l& o1 X( t5 J
* P+ x+ B& v6 a7 ^0 ^
Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, and Strong RK. The neutrophil lipocalin Ngal is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10: 1033-1043, 2002.& {! V! `* F& a/ M4 l9 C

; E* ~& @3 e9 t8 A5 C! i+ T+ _( p" f# E% Z! P

. O  g. b2 t3 \8 Q6 o" [' NGrobstein C. Inductive interaction in the development of the mouse metanephros. J Exp Zool 13: 319-339, 1955.
2 a. l  N5 X8 H8 C' ~0 e) w- k
' o( ?! G) b- i2 E% T" E- g8 W2 ]# P2 v

# D$ P% g, ~6 ^( L1 `8 bGruenheid S, Canonne-Hergaux F, Gauthier S, Hackam DJ, Grinstein S, and Gros P. The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J Exp Med 189: 831-841, 1999.
1 h+ r+ X$ M1 I0 Q
& \$ q; ^3 ]$ t0 d- F
  x# L  f. ]% Q/ y6 `, T3 s& h7 R3 q# D4 |: S( {% ^7 E# {& [
Gruenwald P. Stimulation of nephrogenic tissue by normal and abnormal inductors. Anat Rec 86: 321-334, 1943.5 a: m( R# e2 ^; j# [7 ~
% Z/ ]* W( O7 C" p3 y# a

3 O* C6 ]! `6 f, S$ g/ w- P: t6 c+ j& o( G
Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, and Hediger MA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388: 482-488, 1997./ m5 y* W. Y+ _2 n$ ]# ~

' Y8 @; a, A& `$ A; b! O& k* g. C" t9 ^' ^
6 d" K# e  b, a* [
Gutierrez JA and Wessling-Resnick M. Molecular mechanisms of iron transport. Crit Rev Eukaryot Gene Expr 6: 1-14, 1996.
+ V! O1 u& G( H$ h3 I* Y: i* y! T) i8 w' W6 I
- }( k! D3 q- ]# g0 j& f& }9 @1 `1 d0 T

6 r" A9 Y: L) F" \0 e: |% LGutierrez JA, Yu J, Rivera S, and Wessling-Resnick M. Functional expression cloning and characterization of SFT, a stimulator of Fe transport. J Cell Biol 139: 895-905, 1997.
( C+ s( M& I0 ?6 |" Z& y
$ z4 t. |& E& h3 B; ?; F3 e7 N+ F6 h0 u4 l
% |/ N% x; d: X$ R2 z2 {
Gutierrez JA, Yu J, and Wessling-Resnick M. Characterization and chromosomal mapping of the human gene for SFT, a stimulator of Fe transport. Biochem Biophys Res Commun 253: 739-742, 1998.
; i! h9 b) k9 Q" d& b$ e8 U- z; U' I# H/ T2 F

! g+ q8 S( c' w8 w: K0 @% s2 N# i) l0 L; ?: p
Gutteridge JM and Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann NY Acad Sci 899: 136-147, 2000.
/ m7 F" q& l9 T+ i  r& V/ L1 j( h7 u3 `8 S# o& {% L

7 l! Y5 q+ \; B+ @9 a
1 P+ e) ~. U3 ]( p, K- q* h" bGutteridge JM, Mumby S, Koizumi M, and Taniguchi N. "Free" iron in neonatal plasma activates aconitase: evidence for biologically reactive iron. Biochem Biophys Res Commun 229: 806-809, 1996.1 W9 j. ~( S. t. C" ~! Y9 w
/ b1 ~, s0 \8 R/ R  Z4 R  v, Q

2 I# H2 V  m4 Z$ Q3 Q, d9 W9 Q0 ^! b8 ?2 P3 @& A4 s
Gutteridge JM, Paterson SK, Segal AW, and Halliwell B. Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. Biochem J 199: 259-261, 1981.
3 ^* r6 I7 l5 O/ r3 Z
; g4 v7 a6 `2 K7 A6 [4 s8 F! p
$ _' _0 d1 x3 y+ P& ]! {' ^3 L' L9 N2 V5 o4 W
Hamill R, Woods J, and Cook B. Congenital atransferrinemia. A case report and review of the literature. Am J Clin Pathol 96: 215-218, 1991.; r8 n1 |% B6 f' X$ W- B. {5 Q! s% Z) C9 ]
: c. g$ n/ D+ D
) o1 @. {# j* d
# G& b0 ^6 @+ k: @( O
Hayashi A, Wada Y, Suzuki T, and Shimizu A. Studies on familial hypotransferrinemia. Am J Hum Genet 53: 201-213, 1993.
0 F" P; j% Z- w; i7 r0 i3 N1 O
' O9 h& m0 s1 e, S" p2 c% O% `2 F2 i9 H, `6 L2 V5 L

( y* Y1 f0 p$ u# Z! a8 j0 _Hebert SC and Andreoli TE. Control of NaCl transport in the thick ascending limb. Am J Physiol Renal Fluid Electrolyte Physiol 246: F745-F756, 1984.
, w0 X1 Y. z) s, H6 k& E+ i5 j  d: s6 i. R8 [
. i, X$ ?; v# m

0 A0 @8 @+ A, R3 P/ I: DHershko C, Graham G, Bates GW, and Rachmilewitz EA. Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol 40: 255-263, 1978.
& j5 w3 N) w6 P6 I2 W. b
5 J: H6 ]! B* s
$ W! H- e) d, ]* E4 t- Q5 L. K; T
1 e8 I- S8 [( fHraba-Renevey S, Turler H, Kress M, Salomon C, and Weil R. SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene 4: 601-608, 1989.
( L2 K3 T; k$ I/ }. v1 l. T7 E& s5 A, n2 S8 w0 c2 z
) q$ _9 [0 n" H% [% A( i

7 C0 S; J1 z% M$ e6 AHubert N and Hentze MW. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci USA 99: 12345-12350, 2002.
5 M3 Z9 @  m) }0 T% H; z+ k4 Y8 {; ~; o+ H, i
# z) f6 [" M0 _% M

& g! ^+ F4 Z1 O+ O! W8 kHuggenvik J, Craven C, Idzerda R, Bernstein S, Kaplan J, and McKnight G. A splicing defect in the mouse transferrin gene leads to congenital atransferrinemia. Blood 74: 482-486, 1989.
- c/ d# s/ f% l% A9 ?
) A# t9 J4 O" K6 i; g/ G0 W% V; s7 S: a) ^6 N+ l
. {4 Z! O$ W( ~3 u
Hurst JL, Payne CE, Nevison CM, Marie AD, Humphries RE, Robertson DH, Cavaggioni A, and Beynon RJ. Individual recognition in mice mediated by major urinary proteins. Nature 414: 631-634, 2001.( F" u) W$ i1 s) G7 X+ ?/ |
+ L' X0 O% Y6 _

8 i& e# K6 N6 H
0 v: Z( ~, j1 R, ]  P3 J1 V% UItaranta P, Lin Y, Perasaari J, Roel G, Destree O, and Vainio S. Wnt-6 is expressed in the ureter bud and induces kidney tubule development in vitro. Genesis 32: 259-268, 2002.+ F2 ^! N! U+ }# K) _
5 \! e4 i. W# d

; P3 S) w5 P& X% b7 f% T. @" F" V! M6 g' L) u
Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis JC, Hu S, Altrock BW, and Fox GM. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85: 1113-1124, 1996.8 Z- i/ `$ @9 [2 J
8 t) C, Y4 x1 B4 N" s

  i" T$ g6 F; |% f
) s: o1 a% ?9 @9 UJones R, Peterson C, Grady R, and Cerami A. Low molecular weight iron-binding factor from mammalian tissue that potentiates bacterial growth. J Exp Med 151: 418-428, 1980.0 M8 `/ ^% Z" D2 g! v& V) ~, y
4 Q' f$ h. I, i0 G

1 W9 J3 x: w+ s" Y) H/ q* X* C$ Q3 `
6 Z2 D* {3 U6 z- c* x8 xJordan I and Kaplan J. The mammalian transferrin-independent iron transport system may involve a surface ferrireductase activity. Biochem J 302: 875-879, 1994.
- J  h  D* D" X) A& O
/ e' K/ t  l3 H- ^. F% b" ~! W5 ^5 r$ W( h

% k) t' K" t+ j% IKamarainen M, Seppala M, Virtanen I, and Andersson L. Expression of glycodelin in MCF-7 breast cancer cells induces differentiation into organized acinar epithelium. Lab Invest 77: 565-573, 1997.
5 N2 P+ D0 x  v, Q; K6 u4 [6 f) v1 G- F: u4 n5 J3 n& a: p
& E3 T% G: D" z0 m; u. N' t: ^
* X0 I; }2 C" b' G, l/ h4 L' J1 ~9 h
Kanayasu-Toyoda T, Yamaguchi T, Uchida E, and Hayakawa T. Commitment of neutrophilic differentiation and proliferation of HL-60 cells coincides with expression of transferrin receptor. J Biol Chem 274: 25471-25480, 1999.3 Q/ [& O+ w9 \0 W3 s  Z

3 X$ O+ S' ?) H  C  D' I3 @$ T' X. M1 g$ T7 l6 _+ n
. N7 {2 {3 C4 l
Kaplan J, Jordan I, and Sturrock A. Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem 266: 2997-3004, 1991.% `, C: i3 s! j) n5 p& j# f
: b  b) s5 d! H& o) s1 ^* V" B

7 n) b' \" i3 ~/ P. h* N
$ y$ R& e2 F/ X- AKaravanova I, Dove L, Resau J, and Perantoni A. Conditioned media from a rat ureteric bud cell line in combination with bFGF induces complete differentiation of isolated metanephric mesenchyme. Development 122: 4159-4167, 1996.* F' c: i5 d7 e6 e8 j
8 H6 u1 c8 m0 a; k4 H, v

; {/ E9 J$ V3 m3 i7 h1 y
3 e3 J" O3 b; c3 F& o2 `Kjeldsen L, Johnsen A, Sengelov H, and Borregaard N. Isolation and primary structure of Ngal, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268: 10425-10432, 1993.
/ ]) f( j! k5 o8 \; k; u5 d! c! a0 X# A

$ v% j, c3 _: }/ I; ~+ V8 Z+ H; D: D3 L3 h" p
Klausner RD and Rouault T. The molecular basis of iron transport. In: The Harvey Lectures. New York: Wiley, 1998, p. 99-112.* g; i6 ]  Y0 D$ ~0 D
9 T8 `, u! y* u( U3 x

- i& P' I6 I, B. r- d! \9 J% C
0 i3 h' ~& B9 O$ QKnutson MD, Levy JE, Andrews NC, and Wessling-Resnick M. Expression of stimulator of Fe transport is not enhanced in Hfe knockout mice. J Nutr 131: 1459-1464, 2001.2 V: n3 Y* W+ }- e$ p/ k; t
, j# ]8 r7 V0 `& D. @4 Q) ?6 M' l
+ Y  d6 S* ~3 x, f6 {
$ O* F  k6 c* I- m
Koseki C, Herzlinger D, and al-Awqati Q. Apoptosis in metanephric development. J Cell Biol 119: 1327-1333, 1992.
: D' M, \# w& y. `2 K. P. u' `2 P

3 c0 E0 b3 S  d: u( @) t+ m: E
Kozyraki R, Fyfe J, Verroust PJ, Jacobsen C, Dautry-Varsat A, Gburek J, Willnow TE, Christensen EI, and Moestrup SK. Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia. Proc Natl Acad Sci USA 98: 12491-12496, 2001.
1 u2 O( Y; {7 H5 d, d' i& I
6 B. Q  i. m: y) o
" k4 ~- h% R/ s0 m3 Y( _8 M6 f* A. s6 d+ ]0 q. @
Landschulz W and Ekblom P. Iron delivery during proliferation and differentiation of kidney tubules. J Biol Chem 260: 15580-15584, 1985.
& d' n4 j( W2 o$ R( Z% g% i& \& ~$ A9 ?' s* O6 d# H! X5 m8 p

- C- t% x/ b' k+ C$ s$ U6 B" y9 p: @! T5 q0 q
Landschulz W, Thesleff I, and Ekblom P. A lipophilic iron chelator can replace transferrin as a stimulator of cell proliferation and differentiation. J Cell Biol 98: 596-601, 1984.8 a# _' t. g; v/ {

# A4 l* C- A- ]  q) B/ P$ w; E7 \/ {) B' V

# V% k; g! p! Y- X% HLechner M, Wojnar P, and Redl B. Human tear lipocalin acts as an oxidative-stress-induced scavenger of potentially harmful lipid peroxidation products in a cell culture system. Biochem J 356: 129-135, 2001.$ N% x  i. u) o9 H- J* F' V4 w( y

& L) ^4 Z6 I, b2 ~: f7 o) S8 q8 ~% ?, Q& e' i  i
- D3 {0 K; A2 [* a9 c5 E
Levy J, Jin O, Fujiwara Y, Kuo F, and Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet 21: 396-399, 1999.2 Q9 A% D1 Z" u* q+ ?" r+ N0 `: y
- r) J- p. D. M+ e- N5 j
! o: x4 j: d7 k9 k+ i) R+ C
  h& C) {; K7 R) i/ T  W( I+ \
Lieu PT, Heiskala M, Peterson PA, and Yang Y. The roles of iron in health and disease. Mol Aspects Med 22: 1-87, 2001.' ^) L( G: z& \
* w: U* M) o% K  Y8 a% ^

! H. g# i: M7 F0 w8 h# y
6 p; P) B6 `- o0 ]Marino M, Andrews D, Brown D, and McCluskey RT. Transcytosis of retinol-binding protein across renal proximal tubule cells after megalin (gp 330)-mediated endocytosis. J Am Soc Nephrol 12: 637-648, 2001.9 {" O0 E! m0 F5 e
1 o& ?. A6 ?, h2 p$ r

+ ]. i9 o5 k; w6 W% \; m  Y0 L6 K% e. {1 s. ^5 a: Z4 [
McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, Richardson C, Barlow D, Bomford A, Peters TJ, Raja KB, Shirali S, Hediger MA, Farzaneh F, and Simpson RJ. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291: 1755-1759, 2001.
5 |6 z( t8 g" m" \) z( w1 ~! Z! ^( J, t8 h8 E% p
5 C7 Z3 X2 p+ Q1 a1 @
2 x) h* c) N, v
McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, and Simpson RJ. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5: 299-309, 2000.
/ W+ j+ q* m; b7 U/ h# `! E( i  R* H7 E

9 b( a# M6 l! r0 Y# q: R/ r4 R2 S: A& b6 X' F" ?. v1 t+ H2 g+ B/ n- m
Montfort WR, Weichsel A, and Andersen JF. Nitrophorins and related antihemostatic lipocalins from Rhodnius prolixus and other blood-sucking arthropods. Biochim Biophys Acta 1482: 110-118, 2000.
, g" e' m3 r$ F) h2 S
  ]) u" l, j6 k' v9 T) e( q4 t9 h7 ^5 y; g' b
3 ~& A! k; }8 q, ]# b7 ]6 Y- s
Mucignat-Caretta C, Caretta A, and Cavaggioni A. Acceleration of puberty onset in female mice by male urinary proteins. J Physiol 486: 517-522, 1995.. t, h; ~1 {( P- W1 @

4 ~2 E/ l) h' ^8 E" b% l# T" v- `2 a7 ~, q1 {  M! R) D

: L  m1 E( Z* b: }- R& UNeilands J. Siderophores: structure and function of microbial iron transport compounds. J Biol Chem 270: 26723-26726, 1995.
9 B* W! Z; x! v9 M0 v  S2 B' q- ~6 O/ c0 l0 }* j1 |* `
9 t6 T" [/ O4 f( x

! K0 X9 T* v4 mNewcomer M and Ong D. Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochim Biophys Acta 1482: 57-64, 2000.3 x/ _& {( |" x3 _2 R$ C
, p! V( [" }: M
' A2 l' V% J! \. A; g9 Q5 X

3 Y. f* |$ Q- ~* u. }Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, and Vaulont S. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99: 4596-4601, 2002.( B! U! u3 \+ U$ Q" ]: n$ F
) G" ]0 V# H6 T5 S. e! Z5 U! F
% N1 C" k+ d8 `7 J+ m
/ Q, O! G- E& U1 h$ N
Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, and Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110: 1037-1044, 2002.8 C# E1 ~" U" S+ y) [
" {8 R' O% N8 Z% u7 T6 H  k( E5 `, N
, V- Z, r* p2 Q7 [; G
) Y+ j5 g/ h  q
Nielsen B, Borregaard N, Bundgaard J, Timshel S, Sehested M, and Kjeldsen L. Induction of Ngal synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38: 414-420, 1996.
& k: I4 c% T, m2 R+ r. q. k, `' r5 p: S

" j6 T- f: u8 z) f  s1 G
" i* V) }) V( J; M4 ^! N" x6 n) pNittis T and Gitlin JD. The copper-iron connection: hereditary aceruloplasminemia. Semin Hematol 39: 282-289, 2002.
, Z+ l8 d) E  J& _  t: q
) b7 o4 m; J' F0 C8 y7 t: l8 N1 X5 S" m4 {" c) {- G# P% q
, f/ ^- k3 s' Q% h0 Q$ i( z
Norden AG, Lapsley M, Lee PJ, Pusey CD, Scheinman SJ, Tam FW, Thakker RV, Unwin RJ, and Wrong O. Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int 60: 1885-1892, 2001.
6 a" F9 @1 ?& x/ v6 J
2 Z  i/ \  W4 Q( t0 y/ N3 \
$ p" b; O* ]& C" h' q' d% b
0 j  e/ N; k: a0 `5 BOrlic D and Lev R. Fetal monkey absorption of 55Fe from amniotic fluid. Am J Anat 142: 457-469, 1975.( L2 v. K2 @# Q4 `; R: ~

5 r2 o& w1 c, l- Z& |0 v, w9 u2 Z: T6 n

# b, ^  v! ^3 z# L+ p! `4 sOrlic D, Lev R, and Rosenthal WS. Fetal rat utilization of 55Fe absorbed by fetal intestine from swallowed amniotic fluid. Blood 43: 429-436, 1974.- H% |2 F% H5 X4 L0 p: \* q
* g! q: b9 F+ A

  `7 @8 F* y2 E2 b
8 [) ?2 m1 ~! j0 l% p, s' V5 [0 v9 ZPerantoni AO, Dove LF, and Karavanova I. Basic fibroblast growth factor can mediate the early inductive events in renal development. Proc Natl Acad Sci USA 92: 4696-4700, 1995., e, z7 u' a3 C3 S: i
1 y, ~5 r! i. V. [4 |) N. D

, K  A& `, @7 L$ s+ u/ \, B5 C& c, v) v9 [
Persengiev SP, Devireddy LR, and Green MR. Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors. Genes Dev 16: 1806-1814, 2002.
6 T# I) q' |6 d/ ]
. p% U8 h% }% I+ m2 ~  q, j4 J% p' f5 z1 m5 `1 K# p8 K+ j
' K: i7 f. l2 T/ G- m9 s& p
Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, and Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811-7819, 2001.
8 n3 G  w$ W! @$ z2 U5 E: k  f9 K- Y
) X7 M. t; N* ]5 c3 A
- J$ G$ S2 y$ D5 [$ Y" J+ A( ^% o; |; h6 b) b3 y1 ~  F+ j1 Z2 P* f
Plisov SY, Yoshino K, Dove LF, Higinbotham KG, Rubin JS, and Perantoni AO. TGF 2, LIF and FGF2 cooperate to induce nephrogenesis. Development 128: 1045-1057, 2001.; d1 `' S$ b* x
& V' R* S% w) }9 j' G! n' r

) r( T- k/ {5 p& H7 `/ L1 f0 w" V/ P7 A
Ponka P. Cellular iron metabolism. Kidney Int 55: S2-S11, 1999.
/ a/ w: k0 |5 O! _. S
: J2 ~7 J5 b. q2 X9 |( B! N
8 v- ]+ J2 r7 z2 P2 ^4 T+ X
5 V+ W0 x8 c8 X9 o1 Y7 S/ c3 ]Ponka P and Lok CN. The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 31: 1111-1137, 1999.- S, \5 [( |% z" [/ X* o# g

; |+ {& |. a/ u8 y1 E1 v* B; D$ v" I9 x$ Y; R
7 ~2 F8 [0 }! F
Prinsen BH, de Sain-van der Velden MG, Kaysen GA, Straver HW, van Rijn HJ, Stellaard F, Berger R, and Rabelink TJ. Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses. J Am Soc Nephrol 12: 1017-1025, 2001.
8 u, U( m, O& Y# l; U1 Y. D1 n1 q4 m4 t+ k
8 o' S# p! o9 A, d2 b9 Y
5 n& X7 r3 ^" x* J( j  J
Rabinowitz R, Peters MT, Vyas S, Campbell S, and Nicolaides KH. Measurement of fetal urine production in normal pregnancy by real-time ultrasonography. Am J Obstet Gynecol 161: 1264-1266, 1989.0 z& ^% ~- o+ P
# R7 X& k, ^" {* \" R$ M

0 ]7 q) V2 \) Y) x! N6 x! s! h' h: G. M
Ryon J, Bendickson L, and Nilsen-Hamilton M. High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J 367: 271-277, 2002.
' h1 w  p" C0 u: c$ u
3 K7 b% G, B% E- w1 E* H  v' O- _. J7 }& l; t( X+ i

% c6 ~/ O" S, ISahlstedt L, Ebeling F, von Bonsdorff L, Parkkinen J, and Ruutu T. Non-transferrin-bound iron during allogeneic stem cell transplantation. Br J Haematol 113: 836-838, 2001.
: j; S: q0 }. L0 t, r% N# Y1 r# F8 V* E' @! ]1 W1 Q+ c2 x: D
& z% R  P( X; e8 |+ |5 b2 `( v

: e' Q1 d& G+ uSanchez D, Ganfornina M, and Bastiani M. Developmental expression of the lipocalin Lazarillo and its role in axonal pathfinding in the grasshopper embryo. Development 121: 135-147, 1995.- o; ?8 X1 i/ P' d+ v* j

' j3 d) J5 n1 m0 F  _- X1 j$ l7 [! p6 ^7 ~' `) _* V

2 o6 P( {8 D' Y4 X6 o* S& ?% `& XSaxen L. Organogenesis of the Kidney. Cambridge, UK: Cambridge Univ. Press, 1987.) J! c# Y% y$ {' e$ i

# X" Z# ]$ p- k  v8 ^
, e) N7 o, a0 _* U- c# a. ]7 i; r
Scheiber B and Goldenberg H. NAD(P)H:ferric iron reductase in endosomal membranes from rat liver. Arch Biochem Biophys 305: 225-230, 1993.' L0 c* n6 O0 T' k) `: a

$ i$ ^6 Y0 p) ?+ p  g
, d0 q) ]& C- R) o7 I; F. O5 g( N* w: P0 c  I5 `3 e- \, |
Schubert D and LaCorbiere M. Isolation of an adhesion-mediating protein from chick neural retina adherons. J Cell Biol 101: 1071-1077, 1985.
( K1 n  s( H) p; O
' U% i2 R: F1 k( y, N
0 S! o* y4 e4 p7 o3 b9 |" U% x' t6 g# W: D  P+ @
Schuchardt A, Agati V, Larsson-Blomberg L, Costanini F, and Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor. Ret Nature 367: 380-383, 1994.+ c% v( F4 D( [7 ]' ~% }5 P/ O
1 B& \. a' B! u1 t  b( U0 z  i

6 ]; u/ @6 s9 b. I% o
, g3 Y& i3 H. S* U) |3 C: ?Simovich MJ, Conrad ME, Umbreit JN, Moore EG, Hainsworth LN, and Smith HK. Cellular location of proteins related to iron absorption and transport. Am J Hematol 69: 164-170, 2002./ f/ i0 F$ J8 s! n, w5 K
* I& A3 g6 b/ [0 O" n0 ~0 {
3 t0 ?2 b7 Y& ?1 Q* \1 A- D

# O- S# a+ k. c  i4 SSong M, Ramaswamy S, Ramachandran S, Flowers LC, Horowitz IR, Rock JA, and Parthasarathy S. Angiogenic role for glycodelin in tumorigenesis. Proc Natl Acad Sci USA 98: 9265-9270, 2001.
5 F; V. @1 n. Y- n, F2 M( ^; J; a1 \& {' \

( y- ]% J4 k, |9 ?5 h: a+ ?* v4 p1 L# b) a3 D, _. \- b7 S
Sousa MM, Norden AG, Jacobsen C, Willnow TE, Christensen EI, Thakker RV, Verroust PJ, Moestrup SK, and Saraiva MJ. Evidence for the role of megalin in renal uptake of transthyretin. J Biol Chem 275: 38176-38178, 2000.% g, A( b9 X/ q1 l

5 T) R9 J. |% f  o, [* U  U2 i( l4 Q$ K: B
7 g* M* C2 Z' [! O* t/ B' `  {6 l5 G
Sposi N, Cianetti L, Tritarelli E, Pelosi E, Militi S, Barberi T, Gabbianelli M, Saulle E, Kuhn L, Peschle C, and Testa U. Mechanisms of differential transferrin receptor expression in normal hematopoiesis. Eur J Biochem 267: 6762-6774, 2000.
: E; K* `) x6 A4 l- w0 U  c
$ I* ~, }6 p8 p
8 R# W, B: R8 `; C( U5 z& j) D+ e1 E* D8 N; P  u
Stoesz S, Friedl A, Haag J, Lindstrom M, Clark G, and Gould M. Heterogeneous expression of the lipocalin Ngal in primary breast cancers. Int J Cancer 79: 565-572, 1998.
/ T2 Z: _) O2 z9 H) Z7 `+ x* h9 `7 F. O7 [$ y+ Y+ e
' a) s0 S' H6 j6 s7 b
' F$ W- j0 C+ C4 v  `# P, `
Sturrock A, Alexander J, Lamb J, Craven CM, and Kaplan J. Characterization of a transferrin-independent uptake system for iron in HeLa cells. J Biol Chem 265: 3139-3145, 1990.
7 {* s1 S+ w6 n$ x2 B
$ x1 Y0 w( u3 m- g" H' T: F" m2 ^3 o4 m
9 T' J' o# P: r' n- e% }
Tabuchi M, Yoshimori T, Yamaguchi K, Yoshida T, and Kishi F. Human NRAMP2/DMT1, which mediates iron transport across endosomal membranes, is localized to late endosomes and lysosomes in HEp-2 cells. J Biol Chem 275: 22220-22228, 2000.
% Q4 h1 t1 o7 a4 H3 T
, {4 Y0 t7 h7 S& M2 u2 Z7 e
5 L: x7 @) h" Y) u+ E, C
* M& n- [5 E6 ^* yThesleff I, Partanen AM, Landschulz W, Trowbridge IS, and Ekblom P. The role of transferrin receptors and iron delivery in mouse embryonic morphogenesis. Differentiation 30: 152-158, 1985.
, A# D/ M& g7 b% ?" l8 H8 P
, }1 q( p  M+ @( }; ?7 @
; e) [- `: R7 z8 i* q8 m( ~& E. G& E) w( A+ D9 C
Tomac AC, Grinberg A, Huang SP, Nosrat C, Wang Y, Borlongan C, Lin SZ, Chiang YH, Olson L, Westphal H, and Hoffer BJ. Glial cell line-derived neurotrophic factor receptor alpha1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles. Neuroscience 95: 1011-1023, 2000.* E) O+ P1 }! ^3 x

5 B* l/ X$ e4 y  X  b  ]7 Z# u9 C+ w5 [  X  X" T2 `

5 ]- C! G0 U4 g6 N$ \( R3 @/ |8 Y: JTreanor JJ, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, and Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature 382: 80-83, 1996.
- }$ n7 j! a* t8 e8 ?: }) }; V# }  Q+ _! J( y! f

) q/ A. i' v6 W, [
3 O) {, A) A/ t- I" o8 _' S* i1 DTrenor C, Campagna D, Sellers V, Andrews N, and Fleming M. The molecular defect in hypotransferrinemic mice. Blood 96: 1113-1118, 2000.
1 W2 F" f" R5 L/ C* I( N
. k% {) C2 C( Z5 Y+ N9 L* b) u! Y( y8 m) |5 b, N  K

4 f4 S& q: u4 ^Umbreit JN, Conrad ME, Hainsworth LN, and Simovich M. The ferrireductase paraferritin contains divalent metal transporter as well as mobilferrin. Am J Physiol Gastrointest Liver Physiol 282: G534-G539, 2002.  }$ R0 j* N" y8 c5 Y
- w, ?- A, x9 w: ~

# R' W" E- Y- V) O% ~2 {. R8 z* Q+ U" w6 S, L
Vainio S and Muller U. Inductive tissue interactions, cell signaling, and the control of kidney organogenesis. Cell 90: 975-978, 1999.
- ?& d+ V% B: p. C. T
9 R* K" ~7 T3 {/ O( ~- J
) T5 x- G2 C1 m/ Z6 z& j  e- h; p' `
/ E8 Q( o# j2 [  D5 b6 IVan Renswoude J, Bridges K, Harford J, and Klausner R. Receptor-mediated endocytosis of transferrin and the uptake of Fe in K562 cells: identification of a non-lysosomal acidic compartment. PNAS 79: 6186-6190, 1982.  T1 ^8 t/ m" I1 y4 i" j' q

  Z" B9 x% k& j' O3 \% U1 S) `' {) o7 m

3 C, @- l- q+ D5 L4 _Vaziri ND. Erythropoietin and transferrin metabolism in nephrotic syndrome. Am J Kidney Dis 38: 1-8, 2001.
" i5 J/ }$ m9 e9 E8 O- p! e( q8 b) T+ L
6 q" e# N8 `0 R, s6 x/ O$ \

/ g" ?, [# D, D# c- e( m8 i8 p; u! uVogel S, Piantedosi R, O'Byrne SM, Kako Y, Quadro L, Gottesman ME, Goldberg IJ, and Blaner WS. Retinol-binding protein-deficient mice: biochemical basis for impaired vision. Biochemistry 41: 15360-15368, 2002.3 k% U( a2 \# }$ h3 B& [" O
* u" f) y0 V9 B3 M8 d4 ^
3 z8 ?" w/ y8 Y6 O+ A3 W3 o6 T
* n- }! P1 I7 N, r; c
Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier J, and Anderson GJ. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21: 195-199, 1999.
, S5 I: T0 d% A4 X7 j# ~6 l" v6 R0 r' B- }

5 d. X. m0 Z7 ^. ?5 ]/ o1 b! a8 P5 ^# [# }" `9 ^
Ward P, Mendoza-Meneses M, Mulac-Jericevic B, Cunningham G, Saucedo-Cardenas O, Teng C, and Conneely O. Restricted spatiotemporal expression of lactoferrin during murine embryonic development. Endocrinology 140: 1852-1860, 1999.) k( X1 v. T, [  u
$ g0 k, [. e& d

7 M7 ?& d/ u2 O+ t1 k/ j
+ }9 z0 W+ M# Z) J# f9 \Wareing M, Ferguson CJ, Green R, Riccardi D, and Smith CP. In vivo characterization of renal iron transport in the anaesthetized rat. J Physiol 524: 581-586, 2000.
  ?' \8 m. W$ i# j' i% s6 N0 _& J; H/ V0 M
* A) j0 n4 r8 F) ], M1 Q$ U9 L1 r7 Q9 i8 }5 q( f
; O3 Z7 A' L$ ]$ j9 x: w
Weichsel A, Andersen JF, Roberts SA, and Montfort WR. Nitric oxide binding to nitrophorin 4 induces complete distal pocket burial. Nat Struct Biol 7: 551-554, 2000.
& i! E9 n* O6 d0 `  o/ {+ \+ v' x8 K5 {6 V

6 ~, W* ]* s* c3 d' F6 e( t9 e& |/ a
Wu K, Polack A, and Dalla-Favera R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283: 676-679, 1999.! O( z% N* q) j4 F( C

& e3 F0 |/ }7 m( _
% N: l. l: Y9 H5 @# p7 \3 g9 L. o4 n: j7 G6 ]
Xu SY, Pauksen K, and Venge P. Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest 55: 125-131, 1995.! }9 ?* o; u4 m9 |

# Q1 Y+ z7 `/ p7 W) w" o
& G" H9 s5 Y7 N2 e& ?+ p2 L1 U$ M' i9 F- _# Q$ N
Xu SY and Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta 1482: 298-307, 2000.7 e  f7 V- F/ \

; ?8 a, U" @& {* M9 g# P  h5 f% s( ^$ F6 ]' n2 T& y

- n' Y6 r, S' J- @1 \Yamashiro DJ, Tycko B, Fluss SR, and Maxfield FR. Segregation of transferrin to a mildly acidic (pH 6.5) para-Golgi compartment in the recycling pathway. Cell 37: 789-800, 1984.
% {5 z7 T, A% x  r8 v% c9 j8 g+ l, }8 z4 n; `& a+ @0 M8 ^
, ?% `4 m2 h& ~9 a, ^' \- ~/ ^! }
% ^; g3 l& m( P4 ?1 a& ^+ _% U  K
Yan L, Borregaard N, Kjeldsen L, and Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276: 37258-37265, 2001.. K4 u. U& r  g# X1 L5 e! J6 t1 @

/ B  c& X* b- e
9 x, W" v- Z8 Q; I
! X( g8 n2 F( `" Z( D6 `' E: \Yang J, Blum A, Novak T, Levinson R, Lai E, and Barasch J. An epithelial precursor is regulated by the ureteric bud and by the stroma. Dev Biol 246: 296-310, 2002.
" M' H9 B# Z1 g5 f1 h8 n# W1 e+ J' m+ Y, w' ?
8 U* K% _1 }0 D3 y6 U+ ~# i

9 K' |5 Q! p4 l% B. JYang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, Du T, Erdjument-Bromage H, Tempst P, Strong R, and Barasch J. An iron delivery pathway mediated by a lipocalin. Mol Cell 10: 1045-1056, 2002.2 ~1 N% i2 s; ~5 ?

1 z% @% ~+ g9 ]8 ]* Y) o& o/ k2 z% i2 X2 Z
) Q( N5 @  g, ~2 ^7 C. _4 L
Yu J and Wessling-Resnick M. Influence of copper depletion on iron uptake mediated by SFT, a stimulator of Fe transport. J Biol Chem 273: 6909-6915, 1998.) J! p& v2 T# E( t! X
8 q+ l$ X5 @: j2 q
! I& F1 L% J( N! \- c, j6 n
' A: k6 w$ U! f* W! ^. k! A
Zerega B, Cermelli S, Michelis B, Cancedda R, and Cancedda FD. Expression of NRL/NGAL (neu-related lipocalin/neutrophil gelatinase-associated lipocalin) during mammalian embryonic development and in inflammation. Eur J Cell Biol 79: 165-172, 2000.
) Z+ l$ D# f: Y
9 D5 p* A1 H0 H. s7 O1 ^+ p! X& M5 x" s

; ~& U2 m2 j% l7 W7 F$ Q8 C, cZhou H, Ramachandran S, Kim J, Raynor D, Rock J, and Parthasarathy S. Implications in the management of pregnancy. II. Low levels of gene expression but enhanced uptake and accumulation of umbilical cord glycodelin. Fertil Steril 73: 843-847, 2000.

Rank: 2

积分
75 
威望
75  
包包
2193  
发表于 2015-5-26 08:44 |显示全部帖子
你还想说什么啊....  

Rank: 2

积分
84 
威望
84  
包包
1877  
发表于 2015-5-27 14:18 |显示全部帖子
真是汗啊  我的家财好少啊  加油  

Rank: 2

积分
98 
威望
98  
包包
1756  
发表于 2015-6-3 15:32 |显示全部帖子
干细胞之家微信公众号
不错!  

Rank: 2

积分
84 
威望
84  
包包
1877  
发表于 2015-7-9 12:01 |显示全部帖子
干细胞之家是不错的网站

Rank: 2

积分
101 
威望
101  
包包
1951  
发表于 2015-7-16 17:40 |显示全部帖子
真是有你的!  

Rank: 2

积分
72 
威望
72  
包包
1730  
发表于 2015-7-19 10:18 |显示全部帖子
爷爷都是从孙子走过来的。  

Rank: 2

积分
64 
威望
64  
包包
1782  
发表于 2015-8-26 12:24 |显示全部帖子
淋巴细胞

Rank: 2

积分
162 
威望
162  
包包
1724  
发表于 2015-8-28 12:17 |显示全部帖子
我有家的感觉~~你知道吗  

Rank: 2

积分
69 
威望
69  
包包
1788  
发表于 2015-9-2 18:42 |显示全部帖子
快毕业了 希望有个好工作 干细胞还是不错的方向
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2024-4-16 22:23

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.